↓ Skip to main content

Dove Medical Press

Liver Fibrosis Scores and Coronary Artery Disease: Novel Findings in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, August 2023
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
7 Mendeley
Title
Liver Fibrosis Scores and Coronary Artery Disease: Novel Findings in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease
Published in
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, August 2023
DOI 10.2147/dmso.s426102
Pubmed ID
Authors

Chuan Lu, Yan Chen, Yue Zhang, Xin Zhao

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 7 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 7 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 1 14%
Lecturer > Senior Lecturer 1 14%
Other 1 14%
Lecturer 1 14%
Student > Ph. D. Student 1 14%
Other 1 14%
Unknown 1 14%
Readers by discipline Count As %
Medicine and Dentistry 3 43%
Unspecified 1 14%
Biochemistry, Genetics and Molecular Biology 1 14%
Pharmacology, Toxicology and Pharmaceutical Science 1 14%
Unknown 1 14%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 December 2023.
All research outputs
#16,608,224
of 26,180,352 outputs
Outputs from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#518
of 1,207 outputs
Outputs of similar age
#181,022
of 366,355 outputs
Outputs of similar age from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#5
of 27 outputs
Altmetric has tracked 26,180,352 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,207 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.2. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 366,355 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.